9 results
Upper GI Bleed - Stigmata of recent hemorrhage - Prevalence and Risk of Rebleeding.
The stigmata of
Upper GI Bleed - ... recent hemorrhage are ... receive endoscopic therapy ... #Diagnosis #Gastroenterology ... #UpperGI #Rebleeding
Forrest Classification of Upper GI Bleeding
Acute Hemorrhage
  Ia - Active Spurting, Re-bleeding Risk 60-100%
Classification of Upper ... Spurting, Re-bleeding ... Oozing, Re-bleeding ... Classification #Upper ... diagnosis #endoscopy #gastroenterology
Endoscopic Therapy in Upper Gastrointestinal Bleeding

 • Risk Stratification
 • Red Blood Cell Transfusion
 • Pre-Endoscopic
in Upper Gastrointestinal ... Bleeding • ... Transfusion • Pre-Endoscopic ... Endoscopy #UGIB #Upper ... #management #gastroenterology
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
Esophageal Variceal Bleeding ... Vasoconstrictor therapy ... , consider for active ... acute settings - Pre-endoscopic ... diagnosis #management #algorithm
Endoscopy - Management of Bleeding Esophageal Varices 
What to Band?
 - Always find the varix that
but anticipate active ... in the mid or upper ... - If with an actively ... patient is not actively ... Tricks #management #gastroenterology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... Progression: • Upper ... involvement - seeding ... Langerhans giant cells are
Endoscopy in Non-Variceal Upper GI Bleeding - Scoping Summary
Pre-Endoscopic Care:
 • Adequate resuscitation: Restrictive> Liberal strategy
in Non-Variceal Upper ... GI Bleeding - Scoping ... protection/AMS/active ... Assessment and Therapy ... diagnosis #management #algorithm
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
terminal alveoli and are ... inhibitors • Injection ... Progression: • Upper ... involvement - seeding ... Langerhans giant cells are
Achalasia Summary

Epidemiology: 10 cases per 100,000 individuals

Defined by inadequate relaxation of the LES and aperistalsis
Primary or
Epidemiology: 10 cases per ... secondary causes leading ... the first-line therapy ... pressure (eg, injection ... management #treatment #gastroenterology